Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

Who May Qualify: 1. Documented diagnosis of diabetes mellitus by definition. 2. Understanding of the Study and willingness and ability to sign willing to sign a consent form 3. Patient age 18 or above 4. Diagnostic for diabetes: 4a) Type 1 diabetes of a lest 5 years of evolution; or 4b) Type 2 diabetes Who Should NOT Join This Trial: -1. Patients under 18 years of age; 2. Failure to give willing to sign a consent form; 3. Presence of retinal diseases - acquired disease: age-related macular degeneration (AMD), occlusion of retinal vessels (ORV), etc.; birth defects: coloboma of choroid or optic nerve disc, etc.; hereditary diseases: retinitis pigmentosa, angioid streaks of the retina, etc. 4\. A patient who has already undergone treatment (surgery, laser, etc.) for any disease of the retina: age-related macular degeneration (AMD), retinal vascular occlusion (ARV), etc. These patients should be excluded or allocated to a separate group. Always talk to your doctor about whether this trial is right for you.